LogicBio Therapeutics to Hold Virtual-Only Annual Meeting of Stockholders
Stockholders will have the same rights and opportunities to participate in the virtual meeting as they would have at an in-person meeting. To gain access to the meeting, stockholders must go to the meeting website at http://www.meetingcenter.io/273338066. The password for the meeting is LOGC2020. The virtual meeting website will contain additional details regarding participation in the 2020 Annual Meeting.
Whether or not stockholders plan to virtually attend the 2020 Annual Meeting, LogicBio urges all stockholders to vote and submit their proxy in advance of the meeting by one of the methods described in the proxy materials for the 2020 Annual Meeting. Stockholders who have previously voted do not need to take any further action.
As described in the proxy statement for the 2020 Annual Meeting, stockholders are able to participate if:
- They were registered stockholders as of the close of business on
April 22, 2020, or
- They hold a legal proxy for the 2020 Annual Meeting.
Beneficial owners as of the record date (i.e., shares held in “street name” through an intermediary, such as a bank or broker) must register in advance to attend and vote at the 2020 Annual Meeting. To register, stockholders must obtain a legal proxy from the holder of record and submit proof of legal proxy reflecting the number of shares of LogicBio common stock held as of the record date, along with their name and email address, to Computershare at firstname.lastname@example.org. Requests for registration must be labeled as “Legal Proxy” and must be received no later than
To be admitted to the virtual 2020 Annual Meeting, stockholders will need to enter the 15-digit control number found on their proxy card (for registered stockholders) or the email confirmation of registration (for beneficial stockholders who properly registered in advance).
Previously distributed proxy cards and voting instruction forms will not be updated to reflect the change from an in-person meeting to a virtual-only meeting and may continue to be used to vote shares in connection with the 2020 Annual Meeting.
For further information, please refer to the Company’s proxy statement and Notice Regarding the Availability of Proxy Materials, filed with the
Guests may participate in a listen-only mode. No control number is required.
For more information, please visit www.logicbio.com.
Associate Director, Investor Relations
Source: LogicBio Therapeutics